219 related articles for article (PubMed ID: 34462814)
1. Progranulin and Activin A Concentrations are Elevated in Serum from Patients with Acute Exacerbations of Idiopathic Pulmonary Fibrosis.
Xie T; Han L; Chen Y; Wu H
Lung; 2021 Oct; 199(5):467-473. PubMed ID: 34462814
[TBL] [Abstract][Full Text] [Related]
2. Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF.
Tóth NM; Müller V; Nagy T; Polivka L; Horváth P; Bohács A; Eszes N
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298130
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Qiu M; Chen Y; Ye Q
Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
[TBL] [Abstract][Full Text] [Related]
5. Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis.
Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respirology; 2020 Mar; 25(3):275-280. PubMed ID: 31270920
[TBL] [Abstract][Full Text] [Related]
6. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
[TBL] [Abstract][Full Text] [Related]
7. Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis.
Tanaka K; Enomoto N; Hozumi H; Isayama T; Naoi H; Aono Y; Katsumata M; Yasui H; Karayama M; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Respir Investig; 2021 Nov; 59(6):827-836. PubMed ID: 34154976
[TBL] [Abstract][Full Text] [Related]
8. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
9. Acute Exacerbation and Proposed Criteria for Progressive Pulmonary Fibrosis in Patients with Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis.
Okuda R; Takemura T; Misumi T; Nagasawa R; Iwasawa T; Baba T; Hagiwara E; Ogura T
Respiration; 2023; 102(9):803-812. PubMed ID: 37619546
[TBL] [Abstract][Full Text] [Related]
10. Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis.
Enomoto N; Oyama Y; Enomoto Y; Mikamo M; Karayama M; Hozumi H; Suzuki Y; Kono M; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Clin Respir J; 2018 Aug; 12(8):2378-2389. PubMed ID: 29873202
[TBL] [Abstract][Full Text] [Related]
11. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
[TBL] [Abstract][Full Text] [Related]
12. The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis.
Hanaka T; Kido T; Noguchi S; Yamada S; Noguchi H; Guo X; Nawata A; Wang KY; Oda K; Takaki T; Izumi H; Ishimoto H; Yatera K; Mukae H
BMC Pulm Med; 2019 Dec; 19(1):265. PubMed ID: 31888585
[TBL] [Abstract][Full Text] [Related]
13. Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema.
Zantah M; Dotan Y; Dass C; Zhao H; Marchetti N; Criner GJ
Respir Res; 2020 Jun; 21(1):164. PubMed ID: 32605574
[TBL] [Abstract][Full Text] [Related]
14. Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Enomoto N; Oyama Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Kono M; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Sci Rep; 2019 Jul; 9(1):10484. PubMed ID: 31324858
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of alveolar levels of activin B, but not activin A, in lungs of west highland white terriers with idiopathic pulmonary fibrosis and diffuse alveolar damage.
Lilja-Maula L; Syrjä P; Laurila HP; Sutinen E; Palviainen M; Ritvos O; Koli K; Rajamäki MM; Myllärniemi M
J Comp Pathol; 2015; 152(2-3):192-200. PubMed ID: 25555634
[TBL] [Abstract][Full Text] [Related]
16. Association of serum macrophage-mannose receptor CD206 with mortality in idiopathic pulmonary fibrosis.
Zou R; Gui X; Zhang J; Tian Y; Liu X; Tian M; Chen T; Wu H; Chen J; Dai J; Cai H
Int Immunopharmacol; 2020 Sep; 86():106732. PubMed ID: 32622200
[TBL] [Abstract][Full Text] [Related]
17. Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review.
Luppi F; Cerri S; Taddei S; Ferrara G; Cottin V
Intern Emerg Med; 2015 Jun; 10(4):401-11. PubMed ID: 25672832
[TBL] [Abstract][Full Text] [Related]
18. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
[TBL] [Abstract][Full Text] [Related]
19. Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis.
Kishaba T; Hozumi H; Fujisawa T; Nei Y; Enomoto N; Sugiura H; Kitani M; Suda T
Respir Investig; 2020 May; 58(3):177-184. PubMed ID: 32205147
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y;
Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
